Y-j Chang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts.

Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts.

Journal: Bone marrow transplantation

Published: June 25, 2017

Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.

Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.

Journal: Bone marrow transplantation

Published: April 15, 2017

Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.

Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation

Published: April 18, 2016

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.

Journal: Journal of translational medicine

Published: December 23, 2015

The impact of donor characteristics on the immune cell composition of second allografts in Chinese people.

The impact of donor characteristics on the immune cell composition of second allografts in Chinese people.

Journal: Vox sanguinis

Published: July 03, 2015

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.

Journal: Bone marrow transplantation

Published: June 29, 2015

Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.

Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.

Journal: Bone marrow transplantation

Published: June 04, 2015

Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT.

Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT.

Journal: Bone marrow transplantation

Published: September 12, 2014

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Leukemia

Published: August 20, 2014

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.

Journal: British journal of cancer

Published: April 08, 2014

EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation.

EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation.

Journal: Bone marrow transplantation

Published: October 28, 2013

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

Journal: Bone marrow transplantation

Published: August 04, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026